Form EFFECT Kazia Therapeutics Limit
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 25, 2026 4:30 P.M. |
| Form: | F-6 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sovargen doses first patient in paxalisib epilepsy trial, triggering $2M payment
- iMiller Public Relations Marks 15 Years Advancing Digital Infrastructure Communications and Community Engagement
- Comstock Issues Statement Regarding Favorable Summary Judgment in Town of Herndon Litigation
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
